MUC1 and COVID-19: Frix et al. [19] investigated a cohort of 83 COVID-19 patients and found that serum KL-6 was a prognostic biomarker of disease activity and fibrosis in COVID-19; however they did not find any correlation between KL-6 levels and admission to intensive care or mortality.